JAMIE MCALISTER: Open Payments
NPI 1558950774 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 20 payments from 11 companies in 2025. Trend: 2023 $184 · 2024 $310 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $343 |
| Phathom Pharmaceuticals, Inc. | 3 | $124 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Novo Nordisk Inc | 1 | $29 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: Otezla, VOQUEZNA, KRYSTEXXA, XIFAXAN, Ozempic, GVOKE HYPOPEN, CAPLYTA, TRELEGY ELLIPTA.
Industry payments across SC — which companies pay providers there.
